InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Schmidt Donal Ray Jr., Chairman & CEO. Officer active across 1 companies, notably Rapid Therapeutic Science Laboratories, Inc.. In total, 2 disclosures have been logged. The latest transaction was disclosed on 27 December 2021 — Don. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€459,1912,000,000 shares@ €0.2296100.0% of flow
Common Stock
SEC:0001393905-21-000547·
€459,1912,000,000 shares@ €0.22967.90% mcap50.0% of flow
Common Stock
SEC:0001393905-21-000547:0·
2 of 2 declarations
About Schmidt Donal Ray Jr.
Donal Ray Schmidt Jr. is the Chief Executive Officer of Rapid Therapeutic Science Laboratories, Inc. He is responsible for the strategic direction of the company, which focuses on developing innovative therapeutic solutions.
